Adverse event reporting in oncology clinical trials - lost in translation?
about
NOLAN: a randomized, phase 2 study to estimate the effect of prophylactic naproxen or loratadine vs no prophylactic treatment on bone pain in patients with early-stage breast cancer receiving chemotherapy and pegfilgrastim.Serious adverse events of older adults in nursing home and community intervention trials.Reporting guidelines for oncology research: helping to maximise the impact of your research.
P2860
Adverse event reporting in oncology clinical trials - lost in translation?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Adverse event reporting in oncology clinical trials - lost in translation?
@en
Adverse event reporting in oncology clinical trials - lost in translation?
@nl
type
label
Adverse event reporting in oncology clinical trials - lost in translation?
@en
Adverse event reporting in oncology clinical trials - lost in translation?
@nl
prefLabel
Adverse event reporting in oncology clinical trials - lost in translation?
@en
Adverse event reporting in oncology clinical trials - lost in translation?
@nl
P2860
P1476
Adverse event reporting in oncology clinical trials - lost in translation?
@en
P2093
Matthew D Galsky
Shanthi Sivendran
P2860
P304
P356
10.1080/14740338.2016.1175429
P407
P577
2016-04-27T00:00:00Z